Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells

Clinical Cancer Research

Volumn 4, Issue 8, 1998, Pages 1843-1849

  Lollini, Pier Luigi ^a   Landuzzi, Lorena ^a   Frabetti, Flavia ^a   Rossi, Ilaria ^a   Nicoletti, Giordano ^a   Scotlandi, Katia ^b   Serra, Massimo ^b   Baldini, Nicola ^b   De Giovanni, Carla ^a   Nanni, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GELATINASE B;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; EWING SARCOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA;

ANTIGENS, CD40; APOPTOSIS; BIOPSY; BONE NEOPLASMS; CD40 LIGAND; COLLAGENASES; ENZYME INDUCTION; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; OSTEOSARCOMA; RHABDOMYOSARCOMA; SARCOMA, EWING'S; TUMOR CELLS, CULTURED;

EID: 0031848157     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. van Kooten, C., and Banchereau, J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol., 61: 1-77, 1996.
2. Kehry, M. R. CD40-mediated signaling in B cells. Balancing cell survival, growth and death. J. Immunol., 156: 2345-2348, 1996.
3. Kennedy, M. K., Picha, K. S., Fanslow, W. C., Grabstein, K. H., Alderson, M. R., Clifford, K. N., Chin, W. A., and Mohler, K. M. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol., 26: 370-378, 1996.
4. Denfeld, R. W., Hollenbaugh, D., Fehrenbach, A., Weiss, J. M., von Leoprechting, A., Mai, B., Voith, U., Schöpf, E., Aruffo, A., and Simon, J. C. CD40 is functionally expressed on human keratinocytes. Eur. J. Immunol., 26: 2329-2334, 1996.
5. Gaspari, A. A., Sempowski, G. D., Chess, P., Gish, J., and Phipps, R. P. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur. J. Immunol., 26: 1371-1377, 1996.
6. Sempowski, G. D., Chess, P. R., and Phipps, R. P. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J. Immunol., 158: 4670-4677, 1997.
7. Hess, S., and Engelmann, H. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med., 183: 159-167, 1996.
8. Stout, R. D., and Suttles, J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today, 17: 487-492, 1996.
9. Rissoan, M. C., van Kooten, C., Chomarat, P., Galibert, L., Durand, I., Thivolet-Bejui, F., Miossec, P., and Banchereau, J. The functional CD40 antigen on fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin. Exp. Immunol., 106: 481-490, 1996.
10. Pammer, J., Plettenberg, A., Weninger, W., Diller, B., Mildner, M., Uthman, A., Issing, W., Stürzl, M., and Tschachler, E. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol., 148: 1387-1396, 1996.
11. De Giovanni, C., Melani, C., Nanni, P., Landuzzi, L., Nicoletti, G., Frabetti, F., Griffoni, C., Colombo, M. P., and Lollini, P-L. Redundancy of autocrine loops in human rhabdomyosarcoma cells. Induction of differentiation by suramin. Br. J. Cancer, 72: 1224-1229, 1995.
12. Ferracini, R., Di Renzo, M. F., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P-L., Cremona, O., Campanacci, M., and Comoglio, P. M. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene, 10: 739-749, 1995.
13. Bagnara, G. P., Serra, M., Giovannini, M., Badiali, M., Stella, M., Montaldi, A., Granchi, D., Paolucci, P., Rocchi, P., Pession, A., Picci, P., Paolucci, G., Campanacci, M., Tessarollo, L., and Cavazzana, A. O. Establishment and characterization of a primitive neuroectodermal tumor of bone continuous cell line (LAP-35). Int. J. Cell Cloning, 8: 409-424, 1990.
14. Fanslow, W. C., Clifford, K. N., Zappone, J., Alderson, M. R., and Armitage, R. J. CD40 mAb M2 and M3 inhibit CD40 ligand binding and function. In: S. Schlossman, L. Boumsell, W. Gilks, T. Kishimoto, J. Harlan, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. Tedder, and R. Todd (eds.), Leucocyte Typing V, pp. 555-556. Oxford, United Kingdom: Oxford University Press, 1994.
15. Onisto, M., Garbisa, S., Caenazzo, C., Freda, M. P., Di Francesco, C., Nitti, D., Liotta, L. A., and Stetler-Stevenson, W. G. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn. Mol. Pathol., 2: 74-80, 1993.
16. Mechtersheimer, G., Barth, T., Ludwig, R., Staudter, M., and Möller, P. Differential expression of leukocyte differentiation antigens in blue round cell sarcomas. Cancer (Phila.), 71: 237-248, 1993.
17. Malik, N., Greenfield, B. W., Wahl, A. F., and Kiener, P. A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol., 156: 3952-3960, 1996.
18. Yoshizaki, T., Sato, H., Furukawa, M., and Pagano, J. S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA, 95: 3621-3626, 1998.
19. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., and Noelle, R. J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol., 14: 591-617, 1996.
20. Baeuerle, P. A., and Baltimore, D. NF-κB: ten years after. Cell, 87: 13-20, 1996.
21. Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., and Albini, A. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer, 75: 246-253, 1998.
22. Gúedez, L., Mansoor, A., Stetler-Stevenson, W. G., and Stetler-Stevenson, M. TIMP-1 inhibits apoptosis in Burkitt's lymphomas. Proc. Am. Assoc. Cancer Res., 38: 165, 1997.
23. Alexander, C. M., Howard, E. W., Bissell, M. J., and Werb, Z. Rescue of mammary epithelial cell apoptosis and entacin degradation by a tissue inhibitor of metalloproteinase-1 transgene. J. Cell Biol., 135: 1669-1677, 1996.
24. Hayward, A. R., Levy, J., Facchetti, F., Notarangelo, L., Ochs, H. D., Etzioni, A., Bonnefoy, J-Y., Cosyns, M., and Weinberg, A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol., 158: 977-983, 1997.
25. Mackey, M. F., Gunn, J. R., Ting, P. P., Kikutani, H., Dranoff, G., Noelle, R. J., and Barth, R. J., Jr. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res., 57: 2569-2574, 1997.
26. Thomas, W. D., Smith, M. J., Si, Z., and Hersey, P. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int. J. Cancer, 68: 795-801, 1996.
27. van den Oord, J. J., Maes, A., Stas, M., Nuyts, J., Battocchio, S., Kasran, A., Garmyn, M., De Wever, I., and De Wolf-Peeters, C. CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am. J. Pathol., 149: 1953-1961, 1996.
28. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W., and Muschel, R. J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14: 246-258, 1994.